NPR News

Pages

NPR Story
12:54 pm
Wed June 27, 2012

'Who Gets What': Putting A Price On Human Tragedy

Public Affairs

Originally published on Thu June 28, 2012 11:56 am

When a tragedy like the Sept. 11 attacks or the Virginia Tech shooting strikes, shock and grief quickly give way to blame. And when it's time to figure out if and how victims should be compensated, lawyer Kenneth Feinberg's phone rings.

Over the past three decades, Feinberg has developed a unique specialty: overseeing compensation funds by doing the difficult, often contentious and politically charged work of figuring out who deserves payment — and often, how much they will receive.

Read more
The Two-Way
12:49 pm
Wed June 27, 2012

Puny Humans: Robot Plays Rock, Paper, Scissors With 100 Percent Accuracy

A robot hand playing rock, paper, scissor.
Ishikawa Oku Laboratory

We don't know what this says about the relationship between humans and robots. But researchers at the Ishikawa Oku Lab at the University of Toyko have developed a robot hand that can beat a human 100 percent of the time in a game of "rock, paper, scissors."

Read more
The Two-Way
12:45 pm
Wed June 27, 2012

Here's How To Learn What The Supreme Court Says About Health Care

The U.S. Supreme Court, which will be in the news on Thursday.
Alex Wong Getty Images

Originally published on Wed June 27, 2012 1:15 pm

The biggest surprise Thursday morning at the Supreme Court will be if the justices do not issue their most-anticipated decision of the year — on the constitutionality of the Affordable Care Act; the health care overhaul enacted in 2010.

Read more
Shots - Health Blog
12:42 pm
Wed June 27, 2012

FDA Approves First New Weight-Loss Drug In More Than A Decade

Belviq, the first new prescription drug in years to help people lose weight, is expected to be available in four to six months.
Justin Sullivan Getty Images

Originally published on Thu June 28, 2012 11:34 am

For the first time in 13 years, the Food and Drug Administration has approved a new drug to help people lose weight.

The FDA gave the green light to Arena Pharmaceuticals to sell Belviq, or lorcaserin generically, a twice-a-day pill that suppresses appetite and appears to affect metabolism by influencing levels of the brain chemical serotonin.

Read more
The Salt
11:54 am
Wed June 27, 2012

Just What Your Summer Beer Needed, Frozen Foam

Kirin

Originally published on Wed June 27, 2012 12:05 pm

Apparently, it is just what it looks like — frozen foam, on a beer.

Read more

Pages